Inovio Pharmaceuticals is now enrolling RRP patients for a clinical trial to investigate the efficacy of a new immunotherapeutic drug. Please see the following sites for more information:
Connect with fellow patients on our Facebook page, be part of an international RRP Registry, learn about Social Security Disability and learn about adjunctive RRP therapies.
The Recurrent Respiratory Papillomatosis Foundation was created to provide patient/family support, serve as an information resource for patients and practitioners, promote public awareness, and aid in the prevention, cure and treatment of RRP by encouraging and participating in promising RRP research studies.
On June 25th 2020, 34 year old Christina Garner's long battle with RRP came to a tragic end. To quote Christina's father, Rocky, "... our...[Read More]
Please help us and the RRP medical/research community by being part of an international RRP registry. The RRPF has coordinated with CoRDS (an organization that...[Read More]
The Recurrent Respiratory Foundation is deeply saddened by the loss of RRP Warrior, Olivia Chaparro. Olivia was a loved member of the RRP community and...[Read More]
The RRP Foundation is pleased to announce that we are providing funding of $50K for an RRP research study, "Murine Papillomavirus as a model for...[Read More]
The International Papilloma Virus Society along with a number of HPV partner organizations remind the RRP/HPV communities that March 4, 2020 is HPV Awareness Day. ...[Read More]